Next Article in Journal
Benefits, Facilitators, Barriers, and Strategies to Improve Pesticide Protective Behaviors: Insights from Farmworkers in North Carolina Tobacco Fields
Previous Article in Journal
Socioeconomic Status and Health: A New Approach to the Measurement of Bivariate Inequality
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Clonal Diversity of ESBL-Producing Escherichia coli Isolated from Environmental, Human and Food Samples

Department of Microbiology and Parasitology, University of Navarra, 31080 Pamplona, Spain
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2017, 14(7), 676; https://doi.org/10.3390/ijerph14070676
Submission received: 3 May 2017 / Revised: 5 June 2017 / Accepted: 19 June 2017 / Published: 23 June 2017
(This article belongs to the Section Environmental Health)

Abstract

:
This study presents a comprehensive approach of a clonal diversity analysis of 448 Extended-spectrum β-lactamase (ESBL)-producing E. coli isolated from environmental, human and food samples in Spain. The phenotypic confirmation of ESBL production was performed by disc diffusion and microdilution methods, while Polymerase Chain Reaction (PCR) and sequencing were used for the molecular characterization of β-lactamase genes (blaCTX-M, blaSHV, blaTEM, blaOXA). Clonal relationship of isolates was determined by multi-locus sequence typing (MLST). Multidrug resistant strains were present in all the studied niches, with percentages above 50.0%. The most prevalent β-lactamase genes were blaCTXM-14 (26%) and blaCTXM-1 (21.4%), followed by blaSHV-12, blaCTX-M-15 and blaTEM-42. MLST isolates were grouped into 26 clonal complexes (CC) and 177 different sequence types (ST) were detected. Despite the high clonal diversity observed, CC10 was the prevalent and the only CC detected in all niches, while other complexes as CC131 were mainly associated to human isolates. The observed prevalence and diversity of these resistant bacteria across the different environments encourages a One Health approach to prevent and control ESBL dissemination between environment and consumers.

1. Introduction

The discovery of antibiotics marked a milestone in infectious diseases therapy saving millions of lives. However, antibiotic misuse among humans and animals has led to the emergence of antimicrobial resistance. Extended-spectrum β-lactamase enzymes (ESBLs) are currently considered one of the major public health concerns throughout the world [1]. Among Enterobacteriaceae, Escherichia coli is the species that causes the greatest number of infections and has become the main ESBL-producing bacteria. The emergence and wide dissemination of this resistance have important implications in public health due to the risk of clinical treatment failure. Several factors contribute to the spread of ESBLs within and outside of hospitals: the overuse of antibiotics in humans and in food-producing animals [2], agricultural environment [3], food-chain transmission [4,5], water environments [6,7,8] or healthy fecal carriers [9,10]. All these different sources where ESBL bacteria have been isolated were defined as reservoirs that contribute to ESBL transmission. The clinical importance of this resistance is reflected in the number of papers published in the last years that show the increasing prevalence in human isolated Enterobacteriaceae of CTX-M enzymes [1,10,11,12], carbapenemases [13,14] and especially the prevalence of CTX-M-15 in Spain and other European regions [10,15]. In fact, a recent publication of the Organization for Economic Co-operation and Development (OECD) regarding antimicrobial resistance places Spain on the top of European countries in both rates of antibiotic consumption and antimicrobial resistance [16].
However, despite the large amount of studies showing the presence of ESBL Enterobacteriaceae in different sources, there is a lack of information on integrated studies that give a global perspective of the current situation. In fact, the last report of the World Human Organization on antimicrobial resistance points out the importance of integrating surveillance information that would enable comparison of data from food products, and human and environmental strains [1]. Similarly, the One Health initiative emphasizes the connection of human and animal health to environment as well as the need to improve health in these three domains. Therefore, a collaborative and multidisciplinary approach is necessary for controlling the spread of antibiotic resistance [17].
This study follows World Health Organization (WHO) guidelines and tries to connect data from human, animal and environmental niches. The main objective was to characterize the clonal diversity of ESBL-producing Escherichia coli isolated from food products, human samples and different environmental niches in northern Spain in order to gain a better understanding of the diversity and spread pathways of these resistant bacteria.

2. Materials and Methods

2.1. Sampling and Bacterial Isolation

All ESBL-producing strains included in this study were isolated in Navarra (Spain) from 2009 to 2013. Clinical strains were provided by the Clínica Universidad de Navarra and were collected consecutively from January 2009 to December 2012 as part of the routine diagnostics of the laboratory from different human samples (skin, bound exudate, nasal swab, urethral swab, vaginal and perianal swab, bronchial and ascitic aspirates, deep abscess, sputum, drainage catheter, urine and blood). Ethical approval was obtained from the Ethical Committee Research of the University of Navarra (Plan de Investigación de la Universidad de Navarra Project 024/2012). Food and environmental samples were collected from different locations within Navarra (2010–2012), selected in terms of population (>1000 inhabitants). In addition to the already isolated strains from previous studies [18,19], new sampling was performed over a period of two years (2012–2013) to include a higher variety of food and environmental strains. A total of 580 samples of food were collected including vegetables, cheese, fish, sliced cooked meats and fresh meat products made from beef, poultry and pork. With regard to environmental niches, we have analyzed samples from Waste Water Treatment Plant (WWTP), rivers and farm beds (Table 1).
Resistant strains isolation was performed on ChromID ESBL plates (Biomerieux, Marcy l’Etoile, France), a selective medium containing cefpodoxime. Suspicious resistant bacteria were isolated on nutrient agar (Biolife, Milano, Italy) and strain identification was performed by biochemical tests (API 20E and VITEK®, Biomerieux, Marcy l’Etoile, France).

2.2. β-Lactamase Characterization

The phenotypic confirmation of ESBL production was performed by combination disk test and double-disk synergy test. The antimicrobial susceptibility to additional antibiotics and minimum inhibitory concentrations were obtained in MicroScan® system (Siemens AG, Munich, Germany). Following Clinical And Laboratory Standards Institute recommendations ESBL-producing isolates were categorized as sensitive and resistant (including “intermediate resistant” and “totally resistant”) [20].
The presence of β-lactamase genes (blaTEM, blaSHV, blaOXA and blaCTX-M) was detected by using a modification of two multiplex PCR [21,22]. DNA amplification was performed in a DNA thermal cycler GeneAmp® PCR system 2700 (Applied Biosystems Division, Foster City, CA, USA). In order to identify the bla genes a bidirectional DNA sequence analysis was performed by the Macrogen EZ-Seq purification service (Macrogen Europe, Amsterdam, The Netherlands). Each sequence was compared with the sequences included in GenBank and Lahey Clinic web [23].

2.3. MLST Analysis

To determinate the clonal dissemination of ESBL-producing E. coli, a sequence type analysis was performed following the scheme described by Wirth et al. [24] and seven housekeeping genes were amplified and sequenced for each isolate (adk, fumC, gyr, icd, mdh, purA and recA). DNA extraction was performed with a DNeasy® Blood & Tissue kit (Qiagen, Barcelona, Spain) using a pretreatment protocol for Gram-Negative Bacteria. For amplification, 3 μL of DNA extract was mixed with 5 μL of buffer 10× (Bioline, London, UK), 5 μL of dNTPs (Bioline), 1.5 μL of MgCl2 50 mM (Bioline), 2 μL of each primer Sigma-Aldrich, Steinheim, Germany) and 1.5 U of Inmolase™ DNA polymerase (Bioline) in a final volume of 50 μL. The amplification conditions were as follows: 3 min at 94 °C, followed by 30 cycles of 1 min at 95 °C, 1 min at 60 °C (mdh, gyrB, and recA) or 1 min at 64 °C (fumC, icd, purA and adk), 2 min at 72 °C, and a final elongation step of 5 min at 72 °C. Sequence reactions were performed by EZ-Seq Service (Macrogen Europe) and sequences data were imported into the E. coli MLST database website [25] to determine MLST type. These data were analyzed using BioNumerics v7.5 software (Applied Maths, Sint-Martens-Latem, Belgium).

2.4. Statistical Analysis

The results were subjected to statistical processing with the Statistical Package for Social Sciences (SPSS) 15.0 software, (SPSS Inc., Chicago, IL, USA), applying R × C contingency test or Fisher’s exact test depending on the expected frequencies, with a level of significance of p < 0.05.

3. Results and Discussion

3.1. Prevalence in Food and Environmental Samples

Of the 580 food samples analyzed, 19.3% of them were positive for ESBL-producing Enterobacteriaceae (ESBL-E). According to results obtained in a previous study [18], fresh meat samples showed the highest prevalence (56.8%), while none of the cheese samples were positive for ESBL-E (Table 1). It must be pointed out that poultry meat carries a high risk of transmission of these resistant strains due to its high presence in this product (89.3%, data not shown). Similar results have been obtained by Skockova et al. [26], who reported high ESBL-E rates in poultry and pork meat in the Czech Republic. With regard to vegetables, only one out of 306 samples were positive for ESBL-producing E. coli (0.3%). By contrast, high prevalence of other species were observed (Enterobacter spp., Citrobacter spp. and Klebsiella spp.), coinciding with a report by Reuland et al. [27], who isolated Enterobacteriaceae species other than E. coli in raw vegetables in similar levels.
Similarly, a wide distribution of ESBL-E throughout the environment was detected because 43.1% of the analyzed samples were positive for these resistant strains. Higher prevalence was observed on WWTP and farms (>50%), while the presence in rivers was lower than the 36.2% reported in a recent study carried out in Switzerland [28].
The high prevalence observed in meat as well as on farms suggests the circulation of ESBL-producing E. coli from farm animals to food products, and supports the thesis of resistant bacteria spreading throughout the food chain.

3.2. Antimicrobial Resistance

The study of antimicrobial susceptibility points out a high resistance against penicillins, cephalosporins and aztreonam among strains isolated from all niches, combined with co-resistance against quinolones and aminoglycosides (Table 2). In addition, we have observed high susceptibility to carbapenems, coinciding with the results obtained by Egervärn et al. in a study performed on meat imported into Sweden [29]. However, other authors have pointed out the emergence of carbapenem resistance among strains isolated from environmental and clinical samples [13,14,30,31,32].
It must be pointed out that some significant differences regarding antimicrobial resistances in certain antibiotics were observed, depending on the strain origin. For instance, we detected high resistance against cefepime in food and human isolates (94.2% and 94.6%, respectively), while low resistance was observed in farm isolates (2.0%) (p = 0.016). Similar low resistances against cefepime were reported in a study performed in meat from Poland [33]. On the other hand, a high resistance to cefoxitin (FOX) was observed in isolates from water environments (rivers and WWTP) when compared to the other isolates. The diversity of species different to E. coli found in these environments that usually express AmpC (Enterobacter spp., Citrobacter spp., Klebsiella spp.) could be the reason of this high resistance for FOX. In fact, seven out of 11 isolates from vegetables corresponded to species different from E. coli, pointing to irrigation water as the possible origin of contamination as suggested previously. In this paper only E. coli isolates have been characterized for the presence of β-lactamase genes. Therefore, further molecular studies in the remaining species should be performed to check the probable AmpC β-lactamase.
Moreover, we detected high susceptibility against aminoglycosides in the strains isolated from all sources, with the exception of amikacin and isolates from food samples (99.5% resistance). Similar results were detected in a study carried out in Sweden [29]. Among food isolates we have not found differences in antimicrobial resistance between poultry, pork and beef meats. For instance, tetracycline resistance differences were not significant (p = 0.17) between the three meat origins, consistent with the highly extended use of this antimicrobial in European livestock [34]. Moreover high resistance to tetracycline (83.0%) were observed among food isolates strains coinciding with the study performed by Beninati et al. [35], who detected 85.0% of resistant strains against this antimicrobial.
In contrast, we have detected significant differences (p = 0.043) in ciprofloxacin resistance between pork (49.1%), beef (64.3%) and poultry meat (80.4%), which is consistent with the highly extended use of quinolones among poultry farms.
Similarly, clinical isolates showed higher percentage of resistance to quinolones (>70%), in accordance with other European studies [36,37]. Isolates from food also showed high resistance (57.9%) against this antimicrobial family, similar to the data reported by Egervärn et al. [29] Isolates from farm beds showed a percentage of 49.3% of resistance whereas river isolates showed lower percentages.
In addition, a high level of multi-drug resistance (MDR), defined as resistance to three or more structurally unrelated antimicrobial agents, was detected in all niches (Table 2). Food and human isolates showed the highest MDR rates (84.8% and 86.2%, respectively). Similar results were reported by Egervärn et al. [29] regarding food isolates, with levels of multi-resistance between 81 and 98% depending on the type of food. In contrast, Amador et al. [38] observed lower levels of multi-resistance in food in 2009 (31.4%), and lower rates of MDR among human isolates were reported by other authors in 2014 [9,39]. The level of multi-drug resistance observed in strains from other environmental origins was very similar (ranging 60.0%). Similar results were reported by Zurfluh et al. [28] for isolates from rivers and lakes in Switzerland (63.7%). In contrast, Randall et al. [40] found lower levels of MDR E. coli isolated from broiler chickens and turkey samples in Great Britain slaughterhouses.
These drug and multi-drug resistance profiles observed in bacteria isolated from food products can be explained by the misuse of antimicrobials in livestock and agricultural production, as well as the movement of resistance bacteria via sewage and manure. These findings pose an emergent health risk through food consumption and show the actual limitations in therapeutic treatment of infections caused by ESBL-producing bacteria.

3.3. β-Lactamase Genes

Molecular characterization by PCR and sequencing showed that bla genes were present in 75.0% of the strains isolated from food samples, in 86.1% of strains isolated from human samples and in 74.2% of environmental samples. Furthermore, we detected CTX-M-1 and CTX-M-14 producing E. coli in all niches (Table 3).
With regard to food isolates, the most prevalent genes were blaCTX-M-14 (25.0%) and blaCTX-M-1 (23.9%), followed by blaSHV-12 and blaTEM-42. Other bla genes such as blaCTX-M-2 and blaTEM-145 were present in low percentages. In contrast with other studies [10], encoding bla-CTX-M-15 genes were detected only in one food sample, despite the fact that this type was the prevalent among clinical isolates. With respect to isolates from poultry meat, blaCTX-M-14 genes were the most prevalent (34.4%) and a high genotypic variability was observed among these isolates with harbored genes blaCTX-M-1, blaSHV-133, blaSHV-5, blaTEM-145 and blaTEM-52. In contrast, Belmar Campos et al. [41] pointed out the prevalence of blaCTX-M-1 and blaSHV-12 in poultry meat purchased in Germany. We also detected two multidrug resistant E. coli strains with less common phenotypes such as blaCTX-M-8 and blaCTX-M-2, which have been observed by other authors in E. coli, Klebsiella pneumoniae and Proteus mirabilis strains [42]. Among isolates from beef meat, the variability was lower and blaCTX-M-14 genes were also predominant (40%), followed by blaTEM-42 and blaCTX-M-1 genes. However, Egervärn et al. [29] detected higher prevalence of blaCTX-M-1 genes in this meat. Our results showed that 56% of isolates from pork samples harboured blaCTX-M-14 genes while other authors present pork meat as a reservoir of blaCTX-M-1 [21]. With respect to the only strain isolated from vegetables, blaCTX-M-1 was the encoding gene.
In contrast, blaCTX-M-15 was the prevalent gene among clinical isolates (36.9%), followed by blaCTX-M-14 (33.8%), blaOXA-1 (20.0%) and blaTEM-42 (12.0%). The most common ESBL types characterized in this study (CTX-M-15 and CTX-M-14) were also found in other Spanish studies [43,44] which reported a high prevalence of these genes (30.8% and 27.3%, respectively). Meanwhile, blaCTX-M-1 genes were present in 11.5% of isolates and only one strain carried blaCTX-M-3 gene. These results reaffirm the evolution of the prevalence of CTX-M reported years ago by Livermore and Woodford [45] in Spain and detected by other authors more recently [9]. In addition, OXA type enzyme was observed in 26 E. coli isolates, and was combined with CTX-M enzyme in 24 isolates.
With regard to environmental isolates, we determined blaCTX-M-1 as a predominant gene in river samples (37.0%) while blaSHV-12 was prevalent in farm beds (51.0%). In contrast, other studies reported a high prevalence of blaCTXM-1 in pig and chicken farms [46,47]. These differences could be due to different antimicrobial treatments and feeds on livestock farms.

3.4. Clonal Diversity Study

MLST analysis of the ESBL-producing E. coli isolates (n = 448) showed a high clonal diversity regardless of ESBL type (Figure 1) or sample origin (Figure 2). These strains were grouped into 26 different clonal complexes (CC), being CC10 the prevalent clonal complexe in this study (13.3%) and the only one present in all niches (Table 4). It should be noted that CC131 (5.9%) was mainly detected in human samples (n = 26). Finally, other complexes were found in three different niches, as CC23 (5.9%) that was present in WWTP, farm and human samples, or CC155 (2.8%) that was detected in food, WWTP and human isolates.
Overall, 177 different sequence types (ST) were detected. Among these, ST98 was the prevalent one (n = 17), followed by ST617 (n = 13), ST88 (n = 12) and ST648 (n = 11). It must be pointed out that none of strains have been identified as ST131, however 27 strains from food (n = 1) and human samples (n = 26) were included in CC131. The remaining isolates were singletons and did not cluster into any CC.
Food isolates belonged to 14CCs and the most extended ST was ST98 (n = 13), that was the mainly present in chicken meat (62%), followed by ST776 (n = 8) and ST878 (n = 6). We have detected ST648, ST776, ST878 and ST98 among the three classes of meat products analyzed in this study, what indicate a high dissemination regardless of meat origin. Furthermore, we have detected five isolates from beef and chicken samples belonging to ST648 and harbouring blaCTX-M-14 genes. In the same way, Belmar-Campos et al. [41] reported ST648 chicken isolates harbouring blaCTX-M-1 genes. Similarly, previous studies observed ST648 in ESBL-producing strains isolated from human, poultry and wildlife [48,49,50]. These results point out the spread of this ST among several niches in Europe. Otherwise, isolates harbouring blaCTX-M-14, blaCTX-M-1 and blaSHV-12TX-M-14 belonged to ST359 were detected in chicken meat as well as chicken farms what suggests the existence of a ST359 reservoir among poultry niches. In addition, we have detected only one isolate from pig meat belonged to CC131 (ST2433), traditionally associated to more virulent strains. Finally, other clones as ST57 harbouring blaCTX-M-14 gene have been detected in different niches (food, WWTP, human samples), what suggests that the dissemination of ESBL genes in E. coli may occur through multiple routes including food chain.
WWTP isolates were scattered among 12 CC that included 64STs, the remaining isolates were singletons and did not cluster into any CC. ST611 and ST844 were the most common (n = 14), followed by ST615 and ST617 (n = 10). ST10 was also a common genotype. Regarding ST611 (CC157), in addition to WWTP environment we have detected this clone among chicken, beef and human samples, associated to SHV-12 and TEM-42 production. Other studies observed this clonal complex among human, poultry and wildlife [51,52]. Moreover, CC10 isolates harbouring blaCTX-M-1 have been observed in different environments and blaCTX-M-14 genes belonged to ST10 were isolated from WWTP strains (n = 4), farms (n = 3) and human samples (n = 1). Isolates belonging to ST167 were detected in WWTP (n = 3) and human strains (n = 2) harbouring blaCTX-M-14 and blaSHV-12 genes. In addition, strains from WWTP (n = 6) and food samples (n = 6) addressed to CC23 (ST88, ST90 y ST650) were associated to CTX-M-14 production. All these results suggest that water systems might act as a reservoir and dissemination route of ESBL resistant genes. Finally, isolates from river samples (n = 26) were scattered among 22 different STs and we have detected several STs that were exclusive of river isolates as ST940, ST298 and ST1196.
Regarding farm isolates we have found four CCs, being ST88 the prevalent ST (n = 6). All this strains were isolated from poultry farms and were associated to CTX-M-1 (n = 5) and SHV-12 production (n = 1). Other detected sequences were ST878 (n = 5) and ST619 (n = 5), associated to SHV-12 production in the first case and SHV-12 and CTX-M-1 production in the second one. We have also detected from a swine farm, a multirresistant strain that belong to ST373 (CC168) and harbour blaCTX-M-1, blaSHV-12 and blaTEM-42 genes.
These results showed the high heterogeneity among farm isolates as well as the risk of transmission to human being through food chain. Similarly, Knapp et al. [53] analyze swine farms and reported high presence of antimicrobial resistant strains and point out this niche as an important reservoir of resistant genes. In addition, we have detected ST648 in chicken, pig and beef meat as well as human samples, what suggest a possible dissemination through food chain.
About 60% of clinical isolates were scattered among 17 CCs, the remaining isolates did not cluster into any CC. A total of 66 different ST were observed, ST3213 was the most common followed by ST88, ST617, ST648 and ST90. We have detected five isolates harbouring blaCTX-M-15 gene that belonged to ST648 that were also reported by other authors in human and animal samples [49,54].
Moreover, Brisse et al. [55] reported a high diversity among E. coli isolated from clinical samples, belonged to 116 STs and 13 CCs. The most common complexes they observed were CC131 (23%), CC10 (15%), CC73 (6%) and CC23 (5%). Similarly, we have detected CC131 (21.6%), CC10 (16.4%), CC23 (16.4%) and CC73 in only one strain (0.9%). According to our study, they also observed a high heterogeneity among CC10 (11 different STs) and CC23 (five different STs). However, Brisse et al. [55] reported high frequency of ST131 meanwhile in our study we have not detected ST131, although we have observed 25 strains from urine samples that belong to CC131 and harbor blaCTX-M-15 gene. The only strain that harbour blaCTX-M-3 gene belonged to ST838 (CC131). These isolates belonged to CC131 are interesting because of the high virulence they could present.
We have also detected two strains that belonged to ST393 (CC131) harbouring blaCTX-M-15 and showing high resistance against quinolones, penicillin, cephalosporin and tetracycline. Other studies reported that strains of this ST were resistant to quinolones and were implicated in extraintestinal infections [56,57].

4. Conclusions

In conclusion, this study demonstrates the multidrug resistance and the clonal diversity of ESBL-producing E. coli isolated from food, environmental and human samples. The MLST profiles of isolates from food were different from human and environmental isolates and it emphasizes the high diversity of these bacteria throughout these niches. However, the unique CC present in all the aforementioned niches was CC10, while CC131 was mainly associated to human isolates. According to WHO’s recommendations in the ’Global action plan on antimicrobial resistance’ [58], there is a need to strengthen knowledge and evidence through research and surveillance so as to improve our understanding of antimicrobial resistance. Therefore, it is essential to control ESBL-producing E. coli spread among animals and environment to minimize human transmission.

Acknowledgments

We are particularly grateful to José Leiva for providing clinical strains included in this study.

Author Contribution

Elena Ojer-Usoz performed the experiments, analyzed the data and wrote the paper. David González and Ana Isabel Vitas conceived and designed the experiments and supervise data analysis.

Conflicts of Interest

The authors declare no conflict of interest. The study was supported by the Research Plan of the University of Navarra (Plan de Investigación de la Universidad de Navarra (PIUNA) Project 024/2012) and a grant of the “Asociación de Amigos de la Universidad de Navarra”. The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.

References

  1. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance. 2014. Available online: http://www.who.int/drugresistance/documents/surveillancereport/en/ (accessed on 12 March 2017).
  2. Angulo, F.J.; Nargund, V.N.; Chiller, T.C. Evidence of an association between use of anti-microbial agents in food animals and anti-microbial resistance among bacteria isolated from humans and the human health consequences of such resistance. J. Vet. Med. Ser. B. 2004, 51, 374–379. [Google Scholar] [CrossRef] [PubMed]
  3. Blaak, H.; Van Hoek, A.; Veenman, C.; Van Leeuwen, A.; Lynch, G.; Van Overbeek, W.M.; de Roda Husman, A.M. Extended spectrum beta-lactamase- and constitutively AmpC-producing Enterobacteriaceae on fresh produce and in the agricultural environment. Int. J. Food Microbiol. 2014, 168, 8–16. [Google Scholar] [CrossRef] [PubMed]
  4. Zogg, A.L.; Zurfluh, K.; Nüesch-Inderbinen, M.; Stephan, R. Characteristics of ESBL-producing Enterobacteriaceae and Methicillinresistant Staphylococcus aureus (MRSA) isolated from Swiss and imported raw poultry meat collected at retail level. Schweiz. Arch. Tierheilkd. 2016, 158, 451–456. [Google Scholar] [CrossRef] [PubMed]
  5. Börjesson, S.; Ny, S.; Egervärn, M.; Bergström, J.; Rosengren, Å.; Englund, S.; Löfmark, S.; Byfors, S. Limited dissemination of extended-spectrum β-lactamase- and plasmid-encoded AmpC-producing Escherichia coli from food and farm animals, Sweden. Emerg. Infect. Dis. 2016, 22, 634–640. [Google Scholar] [CrossRef] [PubMed]
  6. Korzeniewska, E.; Harnisz, M. Extended-spectrum betalactamase (ESBL)-positive Enterobacteriaceae in municipal sewage and their emission to the environment. J. Environ. Manag. 2013, 128, 904–911. [Google Scholar] [CrossRef] [PubMed]
  7. Tissera, S.; Lee, M. Isolation of extended spectrum b-lactamase (ESBL) producing bacteria from urban surface waters in Malaysia. Malays. J. Med. Sci. 2013, 20, 14–22. [Google Scholar] [PubMed]
  8. Zhang, X.X.; Zhang, T.; Fang, H.H. Antibiotic resistance genes in water environment. Appl. Microbiol. Biotechnol. 2009, 82, 397–414. [Google Scholar] [CrossRef] [PubMed]
  9. Fernández-Reyes, M.; Vicente, D.; Gomariz, M.; Esnal, O.; Landa, J.; Onate, E.; Pérez-Trallero, E. High rate of fecal carriage of extended-spectrum-beta-lactamase-producing Escherichia coli in healthy children in Gipuzkoa, Northern Spain. Antimicrob. Agents Chemother. 2014, 58, 1822–1824. [Google Scholar] [CrossRef] [PubMed]
  10. Livermore, D.M.; Cantón, R.; Gniadkowski, M.; Nordmann, P.; Rossolini, G.M.; Arlet, G.; Ayala, J.; Coque, T.M.; Kern-Zdanowicz, I.; Luzzaro, F.; et al. CTX-M: Changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 2007, 59, 165–174. [Google Scholar] [CrossRef] [PubMed]
  11. Ahmed, S.F.; Ali, M.M.; Mohamed, Z.K.; Moussa, T.A.; Klena, J.D. Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community. Ann. Clin. Microbiol. Antimicrob. 2014, 13, 22. [Google Scholar] [CrossRef] [PubMed]
  12. Cantón, R.; Coque, T.M. The CTX-M b-lactamase pandemic. Curr. Opin. Biotechnol. 2006, 9, 466–475. [Google Scholar]
  13. Thomas, C.; Moore, L.; Elamin, N.; Doumith, M.; Zhang, J.; Maharjan, S.; Warner, M.; Perry, C.; Turton, J.F.; Johnstone, C.; et al. Early (2008–2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK. Int. J. Antimicrob. Agents 2013, 42, 531–536. [Google Scholar] [CrossRef] [PubMed]
  14. Pulcrano, G.; Lula, D.V.; deLuca, C.; Roscetto, E.; Vollaro, A.; Rossano, F.; Catania, M.R. Clonal dissemination of Klebsiella pneumoniae ST512 carrying blaKPC-3 in a hospital in Southern Italy. APMIS 2014, 122, 42–46. [Google Scholar] [CrossRef] [PubMed]
  15. Merino, I.; Shaw, E.; Horcajada, J.P.; Cercenado, E.; Mirelis, B.; Pallarés, M.A.; Gómez, J.; Xercavins, M.; Martínez-Martínez, L.; De Cueto, M.; et al. CTX-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain. J. Antimicrob. Chemother. 2016, 71, 2125–2130. [Google Scholar] [CrossRef] [PubMed]
  16. Organization for Economic Co-Operation and Development (OECD). Antimicrobial Resistance in G7 Countries and Beyond: Economic Issues, Policies and Options for Action; OECD: Paris, France, 2015. [Google Scholar]
  17. One Health Initiative. Available online: www.onehealthinitiative.com (accessed on 12 March 2017).
  18. Ojer-Usoz, E.; González, D.; Vitas, A.I.; Leiva, J.; García-Jalón, I.; Febles, A.; Escolano, M.L. Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in meat products. Meat Sci. 2012, 93, 316–321. [Google Scholar] [CrossRef] [PubMed]
  19. Ojer-Usoz, E.; González, D.; García-Jalón, I.; Vitas, A.I. High dissemination of extended-spectrum β-lactamase-producing Enterobacteriaceae in effluents from wastewater treatment plants. Water Res. 2014, 56, 37–47. [Google Scholar] [CrossRef] [PubMed]
  20. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement; Document M100-S22; CLSI: Wayne, NJ, USA, 2012; Volume 32. [Google Scholar]
  21. Colom, K.; Pérez, J.; Alonso, R.; Fernández-Aranguiz, A.; Larino, E.; Cisterna, R. Simple and reliable multiplex PCR assay for detection of blaTEM, blaSHV and blaOXA 1 genes in Enterobacteriaceae. FEMS Microbiol. Lett. 2003, 223, 147–151. [Google Scholar] [CrossRef]
  22. Woodford, N.; Fagan, E.J.; Ellington, M.J. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J. Antimicrob. Chemother. 2006, 57, 154–155. [Google Scholar] [CrossRef] [PubMed]
  23. Lahey Clinic Web, β-Lactamase Classification and Amino Acid Sequences for TEM, SHV and OXA Extended-Spectrum and Inhibitor Resistant Enzymes. Available online: http://www.lahey.org/Studies/ (accessed on 11 February 2017).
  24. Wirth, T.; Falush, D.; Lan, R.; Colles, F.; Mensa, P.; Wieler, L.H.; Karch, H.; Reeves, P.R.; Maiden, M.C.; Ochman, H.; et al. Sex and virulence in Escherichia coli: An evolutionary perspective. Mol. Microbiol. 2006, 60, 1136–1151. [Google Scholar] [CrossRef] [PubMed]
  25. University of Warwick. Escherichia coli MLST Database. Available online: http://mlst.ucc.ie/mlst/dbs/Ecoli (accessed on 12 February 2017).
  26. Skockova, A.; Kolackova, I.; Bogdanovicova, K.; Karpiskova, R. Characteristic and antimicrobial resistance in Escherichia coli from retail meats purchased in the Czech Republic. Food Control 2015, 47, 401–406. [Google Scholar] [CrossRef]
  27. Reuland, E.A.; Al Naiemi, N.; Raadsen, S.A.; Savelkoul, P.H.M.; Kluytmans, J.A.J.W.; Vandenbroucke-Grauls, C.M.J.E. Prevalence of ESBL-producing Enterobacteriaceae in raw vegetables. Eur. J. Clin. Microbiol. 2014, 33, 1843–1846. [Google Scholar] [CrossRef] [PubMed]
  28. Zurfluh, K.; Hächler, H.; Nüesch-Inderbinen, M.; Stephan, R. Characteristics of extended spectrum β-lactamase and carbapenemase producing Enterobacteriaceae isolates from rivers and lakes in Switzerland. Appl. Environ. Microbiol. 2013, 79, 3021–3026. [Google Scholar] [CrossRef] [PubMed]
  29. Egervärn, M.; Börjesson, S.; Byfors, S.; Finn, M.; Kaipe, C.; Englund, S.; Lindblad, M. Escherichia coli with extended-spectrum beta-lactamases or transferable AmpC betalactamases and Salmonella on meat imported into Sweden. Int. J. Food Microbiol. 2014, 171, 8–14. [Google Scholar] [CrossRef] [PubMed]
  30. Isozumi, R.; Yoshimatsu, K.; Yamashiro, T.; Hasebe, F.; Nguyen, B.; Ngo, T.C.; Yasuda, S.P.; Koma, T.; Shimizu, K.; Arikawa, J. blaNDM-1-positive Klebsiella pneumoniae from environment, Vietnam. Emerg. Infect. Dis. 2012, 18, 1383–1384. [Google Scholar] [CrossRef] [PubMed]
  31. Guerra, B.; Fischer, J.; Helmuth, R. An emerging public health problem: Acquired carbapenemase-producing microorganisms are present in food-producing animals, their environment, companion animals and wild birds. Vet. Microbiol. 2014, 171, 290–297. [Google Scholar] [CrossRef] [PubMed]
  32. Doyle, D.; Peirano, G.; Lascols, C.; Lloyd, T.; Church, D.L.; Pitout, J.D.D. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J. Clin. Microbiol. 2014, 50, 3877–3880. [Google Scholar] [CrossRef] [PubMed]
  33. Wasiński, B.; Różańska, H.; Osek, J. Antimicrobial resistance of ESBL and AmpCproducing Escherichia coli isolated from meat. Bull. Vet. Inst. Pulawy 2014, 58, 567–571. [Google Scholar] [CrossRef]
  34. Responsible Use of Medicines in Agriculture Alliance. Available online: http://www.ruma.org.uk/ (accessed on 10 January 2017).
  35. Beninati, C.; Reich, F.; Muscolino, D.; Giarratana, F.; Panebianco, A.; Klein, G.; Atanassova, V. ESBL-Producing Bacteria and Mrsa Isolated From Poultry and Turkey Products Imported from Italy. Czech. J. Food Sci. 2015, 33, 97–102. [Google Scholar] [CrossRef]
  36. Arnan, M.; Gudiol, C.; Calatayud, L.; Liñares, J.; Domínguez, M.A.; Batlle, M.; Ribera, J.M.; Carratalà, J.; Gudiol, F. Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur. J. Clin. Microbiol. Infect. Dis. 2011, 30, 355–360. [Google Scholar] [CrossRef] [PubMed]
  37. Ferech, M.; Coenen, S.; Malhotra-Kumar, S.; Dvorakova, K.; Hendrickx, E.; Suetens, C.; Goossens, H. European surveillance of antimicrobial consumption (ESAC): Outpatient quinolone use in Europe. J. Antimicrob. Chemother. 2006, 58, 423–427. [Google Scholar] [CrossRef] [PubMed]
  38. Amador, P.; Fernandes, R.; Prudêncio, C.; Brito, L. Resistance to beta-lactams in bacteria isolated from different types of Portuguese cheese. Int. J. Mol. Sci. 2009, 10, 1538–1551. [Google Scholar] [CrossRef] [PubMed]
  39. Gibold, L.; Robin, F.; Tan, R.N.; Delmas, J.; Bonnet, R. Four-year epidemiological study of extended-spectrum b-lactamase-producing Enterobacteriaceae in a French teaching hospital. Clin. Microbiol. Infect. 2014, 20, 20–26. [Google Scholar] [CrossRef] [PubMed]
  40. Randall, L.P.; Clouting, C.; Horton, R.A.; Coldham, N.G.; Wu, G.; Clifton-Hadley, F.A.; Davies, R.H.; Teale, C.J. Prevalence of Escherichia coli carrying extended-spectrum blactamases (CTX-M and TEM-52) from broiler chickens and turkeys in Great Britain between 2006 and 2009. J. Antimicrob. Chemother. 2011, 66, 86–95. [Google Scholar] [CrossRef] [PubMed]
  41. Belmar Campos, C.; Fenner, I.; Wiese, N.; Lensing, C.; Christner, M.; Rohde, H.; Aepfelbacher, M.; Fenner, T.; Hentschke, M. Prevalence and genotypes of extended spectrum betalactamases in Enterobacteriaceae isolated from human stool and chicken meat in Hamburg, Germany. Int. J. Med. Microbiol. 2014, 304, 678–684. [Google Scholar] [CrossRef] [PubMed]
  42. Casella, T.; Rodríguez, M.M.; Takahashi, J.T.; Ghiglione, B.; Dropa, M.; Assunção, E.; Nogueira, M.L.; Lincopan, N.; Gutkind, G.; Nogueira, M.C. Detection of blaCTX-M-type genes in complex class 1 integrons carried by Enterobacteriaceae isolated from retail chicken meat in Brazil. Int. J. Food Microbiol. 2015, 197, 88–91. [Google Scholar] [CrossRef] [PubMed]
  43. Oteo, J.; Navarro, C.; Cercenado, E.; Delgado-Iribarren, A.; Wilhelmi, I.; Orden, B.; García, C.; Miguelañez, S.; Pérez-Vázquez, M.; García-Cobos, S.; et al. Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J. Clin. Microbiol. 2006, 44, 2359–2366. [Google Scholar] [CrossRef] [PubMed]
  44. Valverde, A.; Coque, T.M.; Sánchez-Moreno, M.P.; Rollán, A.; Baquero, F.; Cantón, R. Dramatic increase in prevalence of faecal carriage of extended-spectrum beta-lactamase producing Enterobacteriaceae during non-outbreak situations in Spain. J. Clin. Microbiol. 2004, 42, 4769–4775. [Google Scholar] [CrossRef] [PubMed]
  45. Livermore, D.M.; Woodford, N. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 2006, 14, 413–420. [Google Scholar] [CrossRef] [PubMed]
  46. Hammerum, A.M.; Larsen, J.; Andersen, V.D.; Lester, C.H.; Skovgaard Skytte, T.S.; Hansen, F.; Olsen, S.S.; Mordhorst, H.; Skov, R.L.; Aarestrup, F.M.; et al. Characterization of extended-spectrum b-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins. J. Antimicrob. Chemother. 2014, 69, 2650–2657. [Google Scholar] [CrossRef] [PubMed]
  47. Laube, H.; Friese, A.; von Salviati, C.; Guerra, B.; Roesler, U. Transmission of ESBL/AmpC-producing Escherichia coli from broiler chicken farms to surrounding areas. Vet. Microbiol. 2014, 172, 519–527. [Google Scholar] [CrossRef] [PubMed]
  48. Cortes, P.; Blanc, V.; Mora, A.; Dahbi, G.; Blanco, J.E.; Blanco, M.; López, C.; Andreu, A.; Navarro, F.; Alonso, M.P.; et al. Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl. Environ. Microbiol. 2010, 76, 2799–2805. [Google Scholar] [CrossRef] [PubMed]
  49. Nicolas-Chanoine, M.H.; Blanco, J.; Leflon-Guibout, V. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 2008, 61, 273–281. [Google Scholar] [CrossRef] [PubMed]
  50. Guenther, S.; Grobbel, M.; Beutlich, J.; Bethe, A.; Friedrich, N.D.; Goedecke, A.; Lübke-Becker, A.; Guerra, B.; Wieler, L.H.; Ewers, C. CTX-M-15-type extended-spectrum betalactamases-producing Escherichia coli from wild birds in Germany. Environ. Microbiol. Rep. 2010, 2, 641–645. [Google Scholar] [CrossRef] [PubMed]
  51. Bonnedahl, J.; Drobni, M.; Gauthier-Clerc, M.; Hernández, J.; Granholm, S.; Kayser, Y.; Melhus, A.; Kahlmeter, G.; Waldenström, J.; Johansson, A.; et al. Dissemination of Escherichia coli with CTX-M type ESBL between humans and yellow-legged gulls in the south of France. PLoS ONE 2009, 4, e5958. [Google Scholar] [CrossRef] [PubMed]
  52. Simoes, R.R.; Poirel, L.; Da Costa, P.M.; Nordmann, P. Seagulls and beaches as reservoirs for multidrug-resistant Escherichia coli. Emerg. Infect. Dis. 2010, 16, 110–112. [Google Scholar] [CrossRef] [PubMed]
  53. Knapp, C.C.W.; Zhang, W.; Sturm, B.S.M.; Graham, D.W. Differential fate of erythromycin and beta-lactam resistance genes from swine lagoon waste under different aquatic conditions. Environ. Pollut. 2010, 158, 1506–1512. [Google Scholar] [CrossRef] [PubMed]
  54. Bonnedahl, J.; Drobni, P.; Johansson, A.; Hernández, J.; Melhus, A.; Stedt, J.; Olsen, B.; Drobni, M. Characterization, and comparison, of human clinical and black-headed gull (Larus ridibundus) extended-spectrum beta-lactamase-producing bacterial isolates from Kalmar, on the southeast coast of Sweden. J. Antimicrob. Chemother. 2010, 65, 1939–1944. [Google Scholar] [CrossRef] [PubMed]
  55. Brisse, S.; Diancourt, L.; Laouenan, C.; Vigan, M.; Caro, V.; Arlet, G.; Drieux, L.; Leflon-Guibout, V.; Mentré, F.; Jarlier, V.; et al. Phylogenetic distribution of CTX-M- and non-extended-spectrum-beta-lactamase producing Escherichia coli isolates: Group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J. Clin. Microbiol. 2012, 50, 2974–2981. [Google Scholar] [CrossRef] [PubMed]
  56. Blanco, J.; Mora, A.; Mamani, R.; López, C.; Blanco, M.; Dahbi, G.; Herrera, A.; Blanco, J.E.; Alonso, M.P.; García-Garrote, F.; et al. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J. Antimicrob. Chemother. 2011, 66, 2011–2021. [Google Scholar] [CrossRef] [PubMed]
  57. Johnson, J.R.; Menard, M.; Johnston, B.; Kuskowski, M.A.; Nichol, K.; Zhanel, G.G. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 2009, 53, 2733–2739. [Google Scholar] [CrossRef] [PubMed]
  58. Global Action Plan on Antimicrobial Resistance. Available online: http://www.who.int/antimicrobial-resistance/global-action-plan/en/ (accessed on 26 December 2016).
Figure 1. Minimal spanning tree constructed based on the MLST profiles of the 448 ESBL-producing E. coli isolates and coloured according to ESBL genes (Bionumerics v7.5, Sint-Martens-Latem, Belgium).
Figure 1. Minimal spanning tree constructed based on the MLST profiles of the 448 ESBL-producing E. coli isolates and coloured according to ESBL genes (Bionumerics v7.5, Sint-Martens-Latem, Belgium).
Ijerph 14 00676 g001
Figure 2. Minimal spanning tree constructed based on the MLST profiles of the 448 ESBL-producing E. coli isolates and coloured according samples’ origin (Bionumerics v7.5, Sint-Martens-Latem, Belgium).
Figure 2. Minimal spanning tree constructed based on the MLST profiles of the 448 ESBL-producing E. coli isolates and coloured according samples’ origin (Bionumerics v7.5, Sint-Martens-Latem, Belgium).
Ijerph 14 00676 g002
Table 1. Prevalence of ESBL-producing bacteria in the analyzed samples.
Table 1. Prevalence of ESBL-producing bacteria in the analyzed samples.
SourceNo. of Analyzed SamplesNo. of Positive Samples (%)No. of ESBL-Producing EnterobacteriaceaeNo. of ESBL-Producing E. coliNo. of ESBL-Producing E. coli Carrying blaBLEE
Food580112 (19.3)196179150
Fresh meat16996 (56.8)183175149
Vegetables30614 (4.6)1141
Fish371 (2.7)100
Cooked meat341 (2.7)100
Cheese340000
Environment592255 (43.1)252208186
WWTP279163 (58.4)163132117
Rivers22245 (20.3)413026
Farms9147 (51.6)484643
Human a---130112
a Only E. coli isolates were provided by the Clinica Universidad de Navarra.
Table 2. Percentages of resistance against different antimicrobials according to isolates origin.
Table 2. Percentages of resistance against different antimicrobials according to isolates origin.
AntibioticOrigin of Strains
FoodWWTPRiversFarmsHuman
AMP100.0100.0100.0100.099.2
PIP99.5100.0100.0100.099.2
MZ98.5100.0100.0100.099.2
CZ99.5100.0100.0100.097.7
CXM99.1100.0100.0100.096.9
CPD99.5100.0100.0100.096.2
CTX97.197.9100.0100.096.2
CAZ97.680.483.7100.096.2
FOX9.734.643.04.014.6
FEP94.282.318.02.094.6
AZT96.692.087.8100.096.2
AMC18.050.036.310.057.7
AMS79.197.092.068.089.2
TZP1.981.120.04.024.6
ETP0.01.52.00.02.3
MER0.00.00.00.00.8
IMP0.00.00.00.00.0
AK99.50.02.00.08.5
GM10.716.78.08.021.5
TO7.819.58.010.037.7
LV50.038.218.044.070.8
CIP56.841.620.046.072.3
MXF67.052.333.058.075.4
TET83.048.471.072.076.1
TIG0.52.12.00.02.3
COL21.80.024.010.027.7
SXT40.838.027.034.065.4
FOT2.911.922.02.04.6
FM14.626.712.08.010.8
CHL23.713.616.322.033.1
MDR84.865.462.058.086.2
Ampicillin, AMP; piperacillin, PIP; mezlocillin, MZ; cefazolin, CZ; cefuroxime, CXM; cefpodoxime, CPD; cefotaxime, CTX; ceftazidime, CAZ, cefoxitin, FOX; cefepime, FEP; aztreonam, AZT; amoxicillin clavulanic acid, AMC; amoxicillin sulbactam, AMS; piperacillin tazobactam, TZP; ertapenem, ETP; meropenem, MER; imipenem, IMP; Amikacin, AK; gentamicin, GM; tobramycin, TO; levofloxacin, LV; ciprofloxacin, CIP; moxifloxacin, MXF; tetracycline, TET; tigecycline, TIG; colistin, COL; trimethoprim sulfamethoxazole, SXT; fosfomycin, FOT; nitrofurantoin, FM; chloramphenicol, CHL. MDR: multi drug resistance.
Table 3. Genotypic characteristics of ESBL-producing E. coli isolated from different sources.
Table 3. Genotypic characteristics of ESBL-producing E. coli isolated from different sources.
Sample OriginNo. of ESBL-ProducingNo. of bla GenesPercentages of Detected bla Genes (%)
CTX-M-14CTX-M-1CTX-M-15TEM-42SHV-12
Food17915025.023.91.212.518.5
WWTP13211724.518.411.111.714.1
Rivers302617.124.49.84.99.8
Farms464315.528.121.416.751.0
Human13011233.511.539.213.110.7
Table 4. Distribution of main Clonal Complexes (CC) detected in human, environmental, and food samples.
Table 4. Distribution of main Clonal Complexes (CC) detected in human, environmental, and food samples.
Clonal ComplexNumber of Isolates
FoodWWTPRiverFarmHuman
CC1021162616
CC1012--5-
CC1311---26
CC15566--1
CC15627--1
CC16843-1-
CC23-7-613
CC35011--1
CC398-1--1
CC4481---2
CC46253-1
CC6486---5
CC69-1--1
CC8651--3

Share and Cite

MDPI and ACS Style

Ojer-Usoz, E.; González, D.; Vitas, A.I. Clonal Diversity of ESBL-Producing Escherichia coli Isolated from Environmental, Human and Food Samples. Int. J. Environ. Res. Public Health 2017, 14, 676. https://doi.org/10.3390/ijerph14070676

AMA Style

Ojer-Usoz E, González D, Vitas AI. Clonal Diversity of ESBL-Producing Escherichia coli Isolated from Environmental, Human and Food Samples. International Journal of Environmental Research and Public Health. 2017; 14(7):676. https://doi.org/10.3390/ijerph14070676

Chicago/Turabian Style

Ojer-Usoz, Elena, David González, and Ana Isabel Vitas. 2017. "Clonal Diversity of ESBL-Producing Escherichia coli Isolated from Environmental, Human and Food Samples" International Journal of Environmental Research and Public Health 14, no. 7: 676. https://doi.org/10.3390/ijerph14070676

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop